Additional file 1 of Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
Misato Tsubokura(Tokyo National Hospital), Hiromichi Matsushita(Tokyo National Hospital), Narikazu Boku(Tokyo Medical University), Moemi Kasane(Tokyo National Hospital), Kan Yonemori(National Cancer Centre Japan), Yukihide Kanemitsu(National Cancer Center), Hiroto Ishiki(Tokyo National Hospital), Hiroyuki Fujimoto(Tokyo National Hospital), Kimihiko Kawamura(Tokyo National Hospital), Ryuzaburo Ohtake(Tokyo National Hospital), S. Nakabayashi(Tokyo National Hospital), Yuko Adegawa(Tokyo National Hospital), Takuji Okusaka(National Cancer Centre Japan), Ken Kato(National Cancer Center Hospital East), Ryuji Tanosaki(National Cancer Center), Nao Iwashita(Tokyo National Hospital), Sayaka Takeuchi(Tokyo National Hospital), Eriko Satomi(National Cancer Centre Japan), Minoru Kojima(Tokai University), Yuki Kase(Yokogawa Electric (Japan))
Cited by 0
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780